Abstract
The efficacy of a 3-day clindamycin-quinine regimen to treat clinical malaria attacks was investigated in 256 children from western Gabon. Treatment was well tolerated by all of the children and its efficacy was higher than 97% by day 20. Thus this 3-day clindamycin-quinine regimen might constitute a potential alternative to chloroquine for treating clinical malarial attacks in children from Gabon.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use*
-
Antimalarials / administration & dosage
-
Antimalarials / adverse effects
-
Antimalarials / therapeutic use*
-
Child
-
Clindamycin / administration & dosage
-
Clindamycin / adverse effects
-
Clindamycin / therapeutic use*
-
Drug Therapy, Combination
-
Female
-
Gabon
-
Humans
-
Malaria, Falciparum / drug therapy*
-
Male
-
Quinine / administration & dosage
-
Quinine / adverse effects
-
Quinine / therapeutic use*
Substances
-
Anti-Bacterial Agents
-
Antimalarials
-
Clindamycin
-
Quinine